MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone

J. Ferreira, A. Lees, O. Rascol, T. Müller, A. Santos, I. Oliveira, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Acute admissions in people with Parkinson’s – More than just frailty

N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)

Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials
12:00pm-1:30pm
Acute movement disorders in Tunisian childhood

H. Benrhouma, H. Klaa, A. Nasri, I. Kraoua, I. Turki (Tunis, Tunisia)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families

M. Carecchio, N.E. Mencacci, G. Zorzi, F. Zibordi, C. Fusco, A. Iodice, L. Veneziano, C. Barzaghi, L. 'RBibo, N. Wood, B. Garavaglia, N. Nardocci (Milan, Italy)

Dystonia and Pediatric Movement Disorders
12:00pm-1:30pm
Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease

H. Ito, T. Kamei (Fujisawa, Japan)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)

Pharmacology
12:00pm-1:30pm
Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Altered inter-hemispheric functional coordination in primary blepharospasm

J. Yang, C. Luo, W. Song, Q. Wei, R. Ou, Y. Hou, Q. Gong, H. Shang (Chengdu, People's Republic of China)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3

A.P. Kleinert-Altamirano, M.O. Fiesco-Roa, K. Brockmann, E. Liebermann-Hernández, C. Marques-Lourenco (Tuxtla Gutiérrez, Mexico)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease

B. Nehru, N. Sharma (Chandigarh, India)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley